MedicinePOM

Rivastigmine

A medicine used to treat mild-to-moderate dementia in Alzheimer's and Parkinson's disease.

Clinical information

Common uses

mild-to-moderate Alzheimer's dementia
dementia associated with Parkinson's disease

Common side effects

feeling sick
being sick
loss of appetite
indigestion
weakness

Cautions

prolonged vomiting or diarrhoea can cause serious dehydration
restart at lowest dose after a break over 3 days
can worsen tremor in Parkinson's disease
care needed with slow heart rate, ulcers, asthma, or seizures

Interactions

metoclopramide — not recommended
beta-blockers — not recommended
cholinergic or anticholinergic drugs — not recommended

Pregnancy: no adequate human data — talk to your doctor

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, rivastigmine tartrate capsule label, setid 52781229-ee82-43f9-a113-4419a611978d (accessed 2026-08-16)

Approved brands & formulations4

Brand name	Dosage form	Strength	Importer	Category
Rivastigmine	Tablet	4.5 mg	—	POM
Rivastigmine	Tablet	1.5 mg	—	POM
Rivastigmine	Tablet	6 mg	—	POM
Rivastigmine	Tablet	3 mg	—	POM